Back to companies

Hualan Biological Engineering Inc: Overview

Hualan Biological Engineering Inc (Hualan Biological) is a biopharmaceutical company that carries out research, development and commercialization of blood products, vaccines, recombinant proteins and other biological products. The company's product portfolio includes hepatitis b human immunoglobulin, human albumin, intravenous human immunoglobulin (pH4), human immunoglobulin, tetanus human immunoglobulin, and freeze-dried human fibrin glue. It also provides products such as zymogen complex, human coagulation factor VIII, human fibrinogen, and rabies immune globulin. Hualan Biological offers blood products under the brand Hualan. The company's products are used in the treatment of hypoalbuminemia, distress syndrome, immunodeficiency disease, bacterial and viral infections, hepatitis B, and hemophilia A. It operates manufacturing facilities in China. Hualan Biological is headquartered in Xinxiang, Henan, China.

Headquarters China

Address No.A1, Hualan Avenue, Xinxiang, Henan, 453003


Telephone 86 373 3559989

No of Employees 2,927

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 002007 (SHE)

Revenue (2020) $687.8M -11.7% (2020 vs 2019)

EPS XXX

Net Income (2020) XXX -19.5% (2020 vs 2019)

Market Cap* $5.5B

Net Profit Margin (2020) XXX -8.8% (2020 vs 2019)

* As of and is in US$

Access premium data and analytics for Hualan Biological Engineering Inc

30+

Clinical Trials

Determine Hualan Biological Engineering Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

11+

Pipeline Drugs

Identify which of Hualan Biological Engineering Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

11+

Marketed Drugs

Understand Hualan Biological Engineering Inc’s commercialized product portfolio to stay one step ahead of the market.

1

Install Base

Install Base provides the user with a holistic as well as granular level view of the product deployments of leading vendors across geographies and sectors. Using the tool users can also get an understanding of various vendors’ products or solutions deployed by a prospect.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Brands
Hepatitis B Human Immunoglobulin Hualan
Human Albumin
Intravenous Human Immunoglobulin (pH4)
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2020 New Product Approvals In June, the company's recombinant exendin-4-Fc fusion protein injection was approved for clinical use in the treatment of diabetes.
2020 Financing Agreements In March, Hualan Biological and other companies invested US$291.9 million in Hualan Biological Engineering.
1992 Incorporation/Establishment The company was founded.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Get Started
Image for loader

Competitor Comparison

Key Parameters Hualan Biological Engineering Inc Sinovac Biotech Ltd Chongqing Zhifei Biological Products Co Ltd Shanghai RAAS Blood Products Co Ltd Henan Lingrui Pharmaceutical Co Ltd
Headquarters China China China China China
City Xinxiang Beijing Chongqing Shanghai Xinyang
State/Province Henan Beijing Chongqing Shanghai Henan
No. of Employees 2,927 4,281 4,800 2,966 2,500
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Ankang Chairman Executive Board 2007 73
Fan Bei Managing Director Executive Board 2022 50
Zhang Baoxian Director; Deputy General Manager Executive Board 2022 51
Xie Junmin Chief Financial Officer; Secretary Senior Management 2013 55
Liu Jun Deputy General Manager Senior Management 2022 46
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer